COVID-19: economic aspects of influenza vaccine prevention
Relevance. A viral pandemic caused by the SARS-CoV-2 coronavirus has led to the development of a new coronavirus disease-2019 (COVID-19). The COVID-19 pandemic has forced the mobilization of all available health system resources. There are separate publications on reducing the risk of developing cor...
Main Authors: | E. A. Zhidkova, E. M. Gutor, Yu. A. Tkachenko, I. V. Rogova, I. A. Popova, K. G. Gurevich |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Izdatelstvo OKI
2021-08-01
|
Series: | Качественная клиническая практика |
Subjects: | |
Online Access: | https://www.clinvest.ru/jour/article/view/572 |
Similar Items
-
Evaluation of Seasonal Inactivated Influenza Vaccines Prophylactic Efficacy
by: K. V. Zhdanov, et al.
Published: (2022-11-01) -
CLINICAL AND ECONOMIC EFFECTIVENESS OF INFLUENZA VACCINATION AT A RECURRENT BRONCHITIS IN CHILDREN
by: O. S. Pozdeyeva, et al.
Published: (2015-08-01) -
100 Years after the Spanish Flu Pandemic. The Evolution of the Influenza Virus and the Development of the Flu Vaccine
by: N. I. Briko
Published: (2018-09-01) -
Russian vaccines against COVID-19: their characteristics, efficacy and safety
by: A. E. Bilev, et al.
Published: (2023-01-01) -
Efficacy and Safety of Peptide Vaccine in Prevention of SARS-CoV-2 Infection: Prospective Study among Healthcare Professionals
by: Leyla S. Namazova-Baranova, et al.
Published: (2022-05-01)